Venous thromboembolism: a collaborative quality improvement model for practitioners, hospitals, and insurers
- 201 Downloads
Venous thromboembolism (VTE) carries significant morbidity and mortality and affects a large portion of hospitalized patients. VTE prophylaxis is rated by the Agency for Healthcare Research and Quality as the most effective of 79 patient safety practices it assessed in 2001. Since 1997, Blue Cross Blue Shield of Michigan/Blue Care Network (BCBSM/BCN) have partnered with Michigan hospitals and providers in statewide registry-based collaborative quality improvement initiatives (CQI) aimed at improving the safety and quality of surgical and medical care; many of these collaborative have a particular focus on VTE prevention. The CQIs are uniquely structured to catalyze hospitals and practitioners to become self-optimizing. In this review, we describe the model BCBSM/BCN and participating Michigan hospitals have developed to improve the prevention and diagnosis of VTE for patients in the state of Michigan.
KeywordsVenous thromboembolism Thromboprophylaxis Managed care Warfarin Low molecular weight heparin
GDB—none, NB—none, SAF—Funding from Blue Cross Blue Shield of Michigan, JBF—Funding from Sanofi-Aventis, BlueCross Blue Shield of Michigan, Mardigian Foundation, Fibromuscular Disease Society of America. Consulting fees from Sanofi-Aventis, Ortho-McNeil, Merck, MH—Funding from Blue Cross Blue Shield of Michigan, PKH—Funding from Sanofi-Aventis, RLP—none, TL—none, DS—none.
- 5.Maynard GSJ (2008) Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. In: Medicine PbtSoH, editor. Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality, RockvilleGoogle Scholar
- 6.Shojania K, Duncan BW, McDonald KM, Wachter RM (2001) Making health care safer: a critical analysis of patient safety practices. Agency for Healthcare Research and Quality, RockvilleGoogle Scholar
- 9.Kaatz S, Golgotiu V, Barnes GD, Gu X, Kozlowski J, Almany SL, Besley D, Ponstein P, Froehlich JB (2011) Time to reach therapeutic anticoagulation for postoperative orthopedic prophylaxis, results of the Michigan anticoagulation quality improvement initiative (MAQI2). XXIII Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting, KyotoGoogle Scholar
- 10.Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V et al (2009) American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am 91:1756–1757PubMedCrossRefGoogle Scholar
- 13.Finks JF English WJ, Carlin AM, Krause KR, Share DA, Banerjee M, Birkmeyer JD, Birkmeyer NJ. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg (in press)Google Scholar
- 14.Nathens AB, McMurray MK, Cuschieri J, Durr EA, Moore EE, Bankey PE, et al (2007) The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma 62:557–562; discussion 62–63Google Scholar
- 15.America CoQoHCi, Medicine Io (2001) Crossing the quality chasm: a new health system for the 21st century, The National Academies Press, WashingtonGoogle Scholar